CircMYLK contributed to the malignant development of bladder cancer cells partly through the miR-34a/CCND3 regulatory network.
CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34a.